Eric P. Christofferson

Partner

Managing Partner, Boston office

Emaileric.christofferson@us.dlapiper.com

Call+1 617 406 6089

Boston

About

Eric Christofferson is an experienced trial, litigation, and investigations lawyer in AKD Partners's Boston Office and is a member of the firm's White Collar group. Immediately prior to joining AKD Partners, Eric served as an Assistant US Attorney for the District of Massachusetts, leading an array of white-collar criminal investigations, trials, and appeals.

Eric, whose practice focuses on the life-sciences, healthcare, and financial services sectors, represents corporations and individuals in government investigations, internal investigations, criminal and regulatory proceedings, and civil litigation. He advises clients in matters implicating the False Claims Act, the Anti-Kickback Statute, the Food Drug & Cosmetic Act (FDCA), the Foreign Corrupt Practices Act (FCPA), and the securities laws, among others. For life-sciences companies in particular, Eric assists clients facing a variety of potential concerns relating to alleged kickbacks, physician interactions, clinical research, product manufacturing, contracting, product promotion, and charitable donations. Similarly, for healthcare providers and related entities, Eric helps clients navigate investigations concerning billing, medical-necessity questions, and alleged kickbacks. Eric has successfully negotiated resolutions with the Department of Justice (DOJ), state attorneys general, and other enforcement entities, and he has advised management and boards of directors concerning both external and internal investigations. Eric is also an experienced courtroom lawyer who has tried over fifteen criminal and civil jury trials during his career.

Areas of FocusLife Sciences Litigation, Arbitration and Investigations White Collar and Corporate Crime

Bar admissionsMassachusetts

EXPERIENCE

False Claims Act

Advised global pharmaceutical company in connection with an industry-wide DOJ False Claims Act investigation concerning alleged violations of the anti-kickback statute based on donations to patient-assistance charities, resulting in a favorable settlement and the dismissal of a parallel inquiry concerning two multiple sclerosis products
Advised global diagnostics company in connection with multiple state and federal investigations concerning equipment sales resulting in potential violations of the federal Anti-Kickback Statute, as well as federal and local false claims act violations, resulting in no enforcement action
Advised global medical-device company in connection with DOJ False Claims Act investigation concerning the contracting for capital equipment and potential violations of the Anti-Kickback Statute, successfully advocating for an intervention declination
Advised large regional medical provider in connection with a DOJ False Claims Act investigation concerning alleged medical billing overcharges, successfully negotiating a resolution without a Corporate Integrity Agreement
Advising medical-software company in connection with a DOJ False Claims Act investigation concerning possible manipulation of software settings that led to reimbursement of unnecessary medical services by Medicare and third-party payers

FDCA

Advised global pharmaceutical company in connection with an internal investigation concerning alleged FDCA violations resulting from manufacturing process deficiencies, including identifying specific remediation recommendations that the company implemented
Advised global medical-device company in connection with an internal investigation concerning alleged deficiencies in quality control for a particular product, including identifying specific remediation recommendations that the company implemented
Advised global pharmaceutical company in connection with an internal investigation concerning alleged off-label promotion by company sales representatives, including identifying specific remediation recommendations that the company implemented

FCPA

Advised global pharmaceutical company concerning an anticorruption investigation by DOJ involving a Middle Eastern subsidiary, successfully advocating for—and securing–a declination
Advised global telecommunications company concerning an anticorruption investigation by DOJ involving a Venezuelan subsidiary, including successfully negotiating a deferred prosecution agreement

Securities

Advised global pharmaceutical company in connection with The Securities and Exchange Commission (SEC) investigation concerning alleged insider trading of company securities, resulting in no action taken
Advised durable medical equipment (DME) manufacturer in connection with SEC investigation concerning alleged material billing fraud, resulting in a no action letter

Individual Representations

Represented executive of global technology company in connection with criminal insider trading investigation, resulting in no charges
Represented executive of financial consulting company in connection with criminal market-manipulation investigation, resulting in no charges
Represented chief compliance officer of pharmaceutical company in connection with criminal fraud and kickback investigation, resulting in no charges

Awards

Chambers USA

Band 3, Massachusetts Litigation: White-Collar Crime & Government Investigations, (2024 – 2025)

Pro Bono

Having served as a federal prosecutor for approximately seven years, Eric is now a member of the Criminal Justice Act (CJA) Panel in Massachusetts and represents on –a pro bono basis–defendants in criminal cases who cannot afford to hire an attorney. In addition, Eric represents individuals serving federal criminal sentences who are seeking "Compassionate Release" from prison because of serious medical conditions. Eric has also helped a Texas family successfully appeal to Federal Emergency Management Agency (FEMA) for additional funds after their home was severely damaged following Hurricane Harvey in 2017.

Education

J.D., Georgetown University Law Center
magna cum laude

A.B., Harvard College
cum laude

Media Mentions